BioVox whitepaper over immunotherapie bij kanker

Octrooien

Geschreven door Caroline Pallard

Dit artikel is alleen beschikbaar in het Engels. Our partner BioVox published a White Paper on 'Cancer Immunotherapy'. NLO's Caroline Pallard joined the expert panel and discussed the IP issues. Download trhe White Paper for free.

The BioVox White Paper on Cancer Immunotherapy showcases innovators and world leaders in this exciting field, including GSK Biologicals, Janssen Immunosciences, Celyad, RXi Pharmaceuticals, eTheRNA, ImmunXperts, iTeos Therapeutics and PDC*line Pharma.

In this issue:

Why is immunotherapy more than the latest hype?
What are the challenges to bring lifesaving innovations to the patient
The price of life: who will pay for these treatments?
Pioneering immunotherapy companies in the picture
Insight in landmark oncology trials
Academic innovations in immunotherapy

Download for free

You may download the White Paper here:

White paper 'Immunotherapy: a cure for cancer?'

pdf - 3.18 MB

Downloaden